These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2671204)

  • 1. [Explanatory essay for researchers who plan to analyse their clinical data using Cox's proportional hazard model].
    Hamajima N; Sasaki R; Shibata A; Suzuki S; Tamakoshi A; Aoki K
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):579-84. PubMed ID: 2671204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hazard ratio estimated from a proportional hazard model including two strongly correlated prognostic factors].
    Hamajima N; Sasaki R; Shibata A; Suzuki S; Tamakoshi A; Aoki K
    Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):1015-9. PubMed ID: 2778377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in multiple myeloma: selection using Cox's proportional hazard model.
    Pasqualetti P; Collacciani A; Maccarone C; Casale R
    Biomed Pharmacother; 1996; 50(1):29-35. PubMed ID: 8672729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Cox's and relative survival models when estimating the effects of prognostic factors on disease-specific mortality: a simulation study under proportional excess hazards.
    Le Teuff G; Abrahamowicz M; Bolard P; Quantin C
    Stat Med; 2005 Dec; 24(24):3887-909. PubMed ID: 16320267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting semiparametric additive hazards models using standard statistical software.
    Schaubel DE; Wei G
    Biom J; 2007 Aug; 49(5):719-30. PubMed ID: 17638295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confidence intervals for the survival function using Cox's proportional-hazard model with covariates.
    Link CL
    Biometrics; 1984 Sep; 40(3):601-9. PubMed ID: 6394063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reformulating the hazard ratio to enhance communication with clinical investigators.
    Moser BK; McCann MH
    Clin Trials; 2008; 5(3):248-52. PubMed ID: 18559414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A SAS macro for parametric and semiparametric mixture cure models.
    Corbière F; Joly P
    Comput Methods Programs Biomed; 2007 Feb; 85(2):173-80. PubMed ID: 17157948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E; Mangone L; Lo Scocco G; Carli P
    Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Cox model: limitations and extensions].
    Quantin C; Asselain B; Moreau T
    Rev Epidemiol Sante Publique; 1990; 38(4):341-56. PubMed ID: 2287801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying Cox regression to competing risks.
    Lunn M; McNeil D
    Biometrics; 1995 Jun; 51(2):524-32. PubMed ID: 7662841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportional odds ratio model for comparison of diagnostic tests in meta-analysis.
    Siadaty MS; Shu J
    BMC Med Res Methodol; 2004 Dec; 4(1):27. PubMed ID: 15588327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing interactions of binary time-dependent covariates with time in cox proportional hazards regression models using cubic spline functions.
    Heinzl H; Kaider A; Zlabinger G
    Stat Med; 1996 Dec; 15(23):2589-601. PubMed ID: 8961465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dealing with the proportional hazards assumption when using the proportional hazards model with a single independent variable.
    Shibata A; Hamajima N; Tamakoshi A; Suzuki S; Sasaki R; Aoki K
    Jpn J Clin Oncol; 1989 Sep; 19(3):195-201. PubMed ID: 2810819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statistical analysis of tumors of the renal pelvis and the ureter--determinants of prognostic significance].
    Nagai T; Takashi M; Sakata T; Takamura S; Okamura K; Sakakibara T; Kanai S; Shimoji T; Miyake K; Sahashi M
    Hinyokika Kiyo; 1991 May; 37(5):475-80. PubMed ID: 1858581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A prospective study on the relationship between body mass index and mortality in middle-aged and elderly people in Japan].
    Ishii T; Momose Y; Esaki H; Une H
    Nihon Koshu Eisei Zasshi; 1998 Jan; 45(1):27-34. PubMed ID: 9565454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RSURV: a function to perform relative survival analysis with S-PLUS or R.
    Giorgi R; Payan J; Gouvernet J
    Comput Methods Programs Biomed; 2005 May; 78(2):175-8. PubMed ID: 15848272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on factors influencing survival in patients with advanced gastric carcinoma after resection by Cox's proportional hazard model].
    Wang S; Sun Z; Wang S
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):433-5. PubMed ID: 9387295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general framework for random effects survival analysis in the Cox proportional hazards setting.
    Sargent DJ
    Biometrics; 1998 Dec; 54(4):1486-97. PubMed ID: 9883547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.